Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

Application of a newly developed high-sensitivity HBsAg chemiluminescent enzyme immunoassay for hepatitis B patients with HBsAg seroclearance.

Shinkai N, Matsuura K, Sugauchi F, Watanabe T, Murakami S, Iio E, Ogawa S, Nojiri S, Joh T, Tanaka Y.

J Clin Microbiol. 2013 Nov;51(11):3484-91. doi: 10.1128/JCM.00726-13. Epub 2013 Aug 14.

2.
3.

Highly sensitive detection of hepatitis B virus surface antigen by use of a semiautomated immune complex transfer chemiluminescence enzyme immunoassay.

Takeda K, Maruki M, Yamagaito T, Muramatsu M, Sakai Y, Tobimatsu H, Kobayashi H, Mizuno Y, Hamaguchi Y.

J Clin Microbiol. 2013 Jul;51(7):2238-44. doi: 10.1128/JCM.00324-13. Epub 2013 May 8.

4.

An improved Abbott ARCHITECT assay for the detection of hepatitis B virus surface antigen (HBsAg).

Lou SC, Pearce SK, Lukaszewska TX, Taylor RE, Williams GT, Leary TP.

J Clin Virol. 2011 May;51(1):59-63. doi: 10.1016/j.jcv.2011.01.019. Epub 2011 Mar 1.

PMID:
21367654
5.

Evaluation of a novel chemiluminescent microplate enzyme immunoassay for hepatitis B surface antigen detection.

Yang L, Song LW, Fang LL, Wu Y, Ge SX, Li H, Yuan Q, Zhang J, Xia NS.

J Virol Methods. 2016 Feb;228:55-9. doi: 10.1016/j.jviromet.2015.11.013. Epub 2015 Nov 23.

PMID:
26615806
6.

[Evaluation and application of a newly developed highly sensitive HBsAg chemiluminescent enzyme immunoassay for chronic hepatitis B patients].

Shinkai N, Tanaka Y, Matsuura K, Kani S, Naganuma H, Mizokami M.

Rinsho Byori. 2010 Nov;58(11):1078-84. Japanese.

PMID:
21229705
7.

Novel monitoring of hepatitis B reactivation based on ultra-high sensitive hepatitis B surface antigen assay.

Shinkai N, Kusumoto S, Murakami S, Ogawa S, Ri M, Matsui T, Tamori A, Toyoda H, Ishida T, Iida S, Tanaka Y.

Liver Int. 2017 Aug;37(8):1138-1147. doi: 10.1111/liv.13349. Epub 2017 Jan 29.

PMID:
27992664
8.

[Development of Highly Sensitive Quantitative HBsAg Reagent and Its Availability].

Moriyama K, Isomura M.

Rinsho Byori. 2015 Jan;63(1):44-52. Review. Japanese.

PMID:
26524878
9.

Clinical performance of the novel DiaSorin LIAISON(®) XL murex: HBsAg Quant, HCV-Ab, HIV-Ab/Ag assays.

Krawczyk A, Hintze C, Ackermann J, Goitowski B, Trippler M, Grüner N, Neumann-Fraune M, Verheyen J, Fiedler M.

J Clin Virol. 2014 Jan;59(1):44-9. doi: 10.1016/j.jcv.2013.10.009. Epub 2013 Nov 7.

PMID:
24268764
10.

[Analysis of clinical characteristics and S gene mutation of hepatitis B virus (HBV) in patients with hepatitis B surface antigen RIA negative and HBV DNA positive].

Sohn YH, Oh HB, Ko SY, Lim YS, Kwon OJ.

Korean J Lab Med. 2009 Jun;29(3):224-30. doi: 10.3343/kjlm.2009.29.3.224. Korean.

11.

The Lumipulse G HBsAg-Quant assay for screening and quantification of the hepatitis B surface antigen.

Yang R, Song G, Guan W, Wang Q, Liu Y, Wei L.

J Virol Methods. 2016 Feb;228:39-47. doi: 10.1016/j.jviromet.2015.11.016. Epub 2015 Nov 23.

PMID:
26615803
12.

Clinical performance of a new hepatitis B surface antigen quantitative assay with automatic dilution.

Liu TW, Yeh ML, Huang CF, Lin IL, Huang JF, Dai CY, Chen YL, Chuang WL, Yu ML.

Kaohsiung J Med Sci. 2015 Jan;31(1):26-33. doi: 10.1016/j.kjms.2014.10.007. Epub 2014 Dec 18.

14.

Quantitative detection of hepatitis B surface antigen by chemiluminescent microparticle immunoassay during lamivudine treatment of chronic hepatitis B virus carriers.

Kohmoto M, Enomoto M, Tamori A, Habu D, Takeda T, Kawada N, Sakaguchi H, Seki S, Shiomi S, Nishiguchi S.

J Med Virol. 2005 Feb;75(2):235-9.

PMID:
15602726
15.

Development of a highly sensitive bioluminescent enzyme immunoassay for hepatitis B virus surface antigen capable of detecting divergent mutants.

Minekawa T, Takehara S, Takahashi M, Okamoto H.

Clin Vaccine Immunol. 2013 Aug;20(8):1255-65. doi: 10.1128/CVI.00186-13. Epub 2013 Jun 12.

16.

Hepatitis B surface antigen quantification as a predictor of seroclearance during treatment in HIV-hepatitis B virus coinfected patients from Sub-Saharan Africa.

Boyd A, Maylin S, Moh R, Mahjoub N, Gabillard D, Eholié SP, Danel C, Anglaret X, Zoulim F, Girard PM, Delaugerre C, Lacombefor K; ANRS 12240 VarBVA study.

J Gastroenterol Hepatol. 2016 Mar;31(3):634-44. doi: 10.1111/jgh.13156.

PMID:
26313291
17.

The reliability of HBV core antibody in serological screening for hepatitis B virus.

Ba Alawi F, Robertson PW, LePage AK, Jayamaha J, Baleriola C, Rawlinson WD.

Pathology. 2013 Aug;45(5):501-5. doi: 10.1097/PAT.0b013e3283631cf9.

PMID:
23842045
18.

Correlation of quantitative assay of HBsAg and HBV DNA levels during chronic HBV treatment.

Ozaras R, Tabak F, Tahan V, Ozturk R, Akin H, Mert A, Senturk H.

Dig Dis Sci. 2008 Nov;53(11):2995-8. doi: 10.1007/s10620-008-0263-5. Epub 2008 Apr 12.

PMID:
18409002
19.

A novel hepatitis B virus surface antigen immunoassay as sensitive as hepatitis B virus nucleic acid testing in detecting early infection.

Matsubara N, Kusano O, Sugamata Y, Itoh T, Mizuii M, Tanaka J, Yoshizawa H.

Transfusion. 2009 Mar;49(3):585-95. doi: 10.1111/j.1537-2995.2008.02026.x. Epub 2008 Dec 12.

PMID:
19192255
20.

Linearized hepatitis B surface antigen and hepatitis B core-related antigen in the natural history of chronic hepatitis B.

Seto WK, Wong DK, Fung J, Huang FY, Liu KS, Lai CL, Yuen MF.

Clin Microbiol Infect. 2014 Nov;20(11):1173-80. doi: 10.1111/1469-0691.12739. Epub 2014 Jul 29.

Supplemental Content

Support Center